Skip to main content
Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.660
-0.030 (-1.78%)
At close: Apr 28, 2026, 4:00 PM EDT
1.650
-0.010 (-0.60%)
Pre-market: Apr 29, 2026, 7:24 AM EDT

Lexicon Pharmaceuticals Revenue

In the year 2025, Lexicon Pharmaceuticals had annual revenue of $49.80M with 60.24% growth. Lexicon Pharmaceuticals had revenue of $5.49M in the quarter ending December 31, 2025, a decrease of -79.31%.

Revenue (ttm)
$49.80M
Revenue Growth
+60.24%
P/S Ratio
14.12
Revenue / Employee
$614,852
Employees
81
Market Cap
703.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202549.80M18.72M60.24%
Dec 31, 202431.08M29.88M2,481.48%
Dec 31, 20231.20M1.07M766.19%
Dec 31, 2022139.00K-159.00K-53.36%
Dec 31, 2021298.00K-23.70M-98.76%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Arvinas 262.60M
Gyre Therapeutics 116.59M
Prime Medicine 4.63M
Absci 2.80M
Allogene Therapeutics 22.00K
Revenue Rankings

LXRX News

More News